Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker Testing

SIMPLE SUMMARY: The predominant histologic type of bladder cancer is urothelial carcinoma (UC). Programmed cell death-ligand 1 (PD-L1) expression levels in UC tumors help clinicians determine which patients are more likely to respond to immuno-oncology (IO) therapies; as such, the harmonization of P...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez-Beltran, Antonio, López-Rios, Fernando, Montironi, Rodolfo, Wildsmith, Sophie, Eckstein, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003923/
https://www.ncbi.nlm.nih.gov/pubmed/33804698
http://dx.doi.org/10.3390/cancers13061424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003923/
https://www.ncbi.nlm.nih.gov/pubmed/33804698
http://dx.doi.org/10.3390/cancers13061424

Ejemplares similares